Integrins as target: first phase III trial launches, but questions remain.

摘要

Cellular glue, signaling molecule, cancer accessory-scientists have described various functions for the integrin cellular receptors since the 1970s. And now they may be adding another role to the list: For the first time, an integrin as a target for cancer therapy has made it to a phase HI clinical trial.